Your session is about to expire
← Back to Search
Light Therapy
Bright White Light (BWL) Litebook for Heart Failure (Light-Heart Trial)
N/A
Waitlist Available
Led By Jeanne Maglione, MD, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
The Light-Heart study is a randomized, double-blind, controlled trial investigating the effects of bright white light (BWL) therapy on depressive symptoms, quality of life, and functioning in patients with Stage B heart failure. The study is a randomized, double-blind, controlled trial of 8 weeks of morning BWL therapy compared with morning dim red light (DRL) treatment in older (60 years or older) 122 Stage B (early, asymptomatic) HF patients.
Eligible Conditions
- Heart Failure
- Depression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Bright White Light (BWL) LitebookExperimental Treatment1 Intervention
Participants will be instructed to use the BWL Litebook for an hour every day for 8 weeks.
Group II: Dim Red Light (DRL) LitebookPlacebo Group1 Intervention
Participants will be instructed to use the DRL (comparison condition) Litebook for an hour every day for 8 weeks.
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,157 Previous Clinical Trials
1,571,297 Total Patients Enrolled
16 Trials studying Heart Failure
56,457 Patients Enrolled for Heart Failure
Retirement Research FoundationOTHER
9 Previous Clinical Trials
1,662 Total Patients Enrolled
Jeanne Maglione, MD, PhDPrincipal InvestigatorUniversity of California, San Diego
Share this study with friends
Copy Link
Messenger